ArticleLiver cancer2026

A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial.

Takeshi Terashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.